250 related articles for article (PubMed ID: 26062775)
1. Combination immunotherapy breakthrough for melanoma.
Brower V
Lancet Oncol; 2015 Jul; 16(7):e318. PubMed ID: 26062775
[No Abstract] [Full Text] [Related]
2. Immunotherapy for the management of advanced melanoma: the next steps.
Zikich D; Schachter J; Besser MJ
Am J Clin Dermatol; 2013 Aug; 14(4):261-72. PubMed ID: 23516145
[TBL] [Abstract][Full Text] [Related]
3. Melanoma: is immunotherapy of benefit?
Faries MB; Morton DL
Adv Surg; 2003; 37():139-69. PubMed ID: 12953631
[No Abstract] [Full Text] [Related]
4. [Advances in immunotherapy for metastatic melanoma].
Oláh J
Magy Onkol; 2017 Jun; 61(2):132-136. PubMed ID: 28585614
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiome and immunotherapy response.
Burki TK
Lancet Oncol; 2017 Dec; 18(12):e717. PubMed ID: 29129446
[No Abstract] [Full Text] [Related]
6. [Prognostic factors and improving treatment of cutaneous melanoma].
Vihinen P; Kähäri VM; Pyrhönen S
Duodecim; 2004; 120(12):1445-56. PubMed ID: 15293705
[No Abstract] [Full Text] [Related]
7. Is sentinel node status predictive of overall survival in patients with melanoma?
Carlson GW
Nat Clin Pract Oncol; 2005 Oct; 2(10):494-5. PubMed ID: 16205765
[No Abstract] [Full Text] [Related]
8. Childhood melanoma.
Jen M; Murphy M; Grant-Kels JM
Clin Dermatol; 2009; 27(6):529-36. PubMed ID: 19880040
[TBL] [Abstract][Full Text] [Related]
9. Determinants of unfavorable presentation of primary cutaneous melanoma.
Fallah M; Kharazmi E; Thomsen H; Sundquist J; Hemminki K
J Am Acad Dermatol; 2011 Jul; 65(1):e5-6. PubMed ID: 21679807
[No Abstract] [Full Text] [Related]
10. Malignant melanoma.
Califano J; Nance M
Facial Plast Surg Clin North Am; 2009 Aug; 17(3):337-48. PubMed ID: 19698915
[TBL] [Abstract][Full Text] [Related]
11. Beating A Cancer Death Sentence.
Friedlaender J
Health Aff (Millwood); 2016 Jul; 35(7):1333-7. PubMed ID: 27385250
[TBL] [Abstract][Full Text] [Related]
12. Commentary: Improved patient outcomes remain elusive after intensive imaging surveillance for high-risk melanoma.
Swetter SM
J Am Acad Dermatol; 2016 Sep; 75(3):525-527. PubMed ID: 27317056
[No Abstract] [Full Text] [Related]
13. Latest advances in chemotherapeutic, targeted, and immune approaches in the treatment of metastatic melanoma.
Shah DJ; Dronca RS
Mayo Clin Proc; 2014 Apr; 89(4):504-19. PubMed ID: 24684873
[TBL] [Abstract][Full Text] [Related]
14. [Malignant melanoma].
Schmid-Wendtner M; Wendtner CM
Dtsch Med Wochenschr; 2012 Dec; 137(49):2548-50. PubMed ID: 23188634
[No Abstract] [Full Text] [Related]
15. Cutaneous melanoma: detecting it earlier, weighing management options.
Lane JE; Dalton RR; Sangueza OP
J Fam Pract; 2007 Jan; 56(1):18-28. PubMed ID: 17217894
[No Abstract] [Full Text] [Related]
16. NICE guidance on ipilimumab for treating previously untreated advanced (unresectable or metastatic) melanoma.
Hall CJ; Doss S; Robertson J; Adam J
Lancet Oncol; 2014 Sep; 15(10):1056-7. PubMed ID: 25328937
[No Abstract] [Full Text] [Related]
17. [New treatments for metastatic melanoma: a first hope].
Robert C; Mateus C
Rev Prat; 2011 Nov; 61(9 Suppl):S1-2. PubMed ID: 22338196
[No Abstract] [Full Text] [Related]
18. Immunotherapy for melanoma.
Kim CJ; Dessureault S; Gabrilovich D; Reintgen DS; Slingluff CL
Cancer Control; 2002; 9(1):22-30. PubMed ID: 11907463
[TBL] [Abstract][Full Text] [Related]
19. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
20. Vaccines for melanoma.
Bystryn JC
Dermatol Clin; 2002 Oct; 20(4):717-25. PubMed ID: 12380059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
